Reversible spastic and pyramidal tract signs in a patient with Parkinson's disease on L-dopa.
D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009128:Muscle Spasticity / Q000139:chemically induced*; D009422:Nervous System Diseases / Q000139:chemically induced; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D011712:Pyramidal Tracts / Q000187:drug effects*
D007980:Levodopa